Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15294883 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Lucentis for New Onset Neovascular Glaucoma
Conditions: Glaucoma;   New Onset Glaucoma;   Neovascular Glaucoma;   New Onset Neovascular Glaucoma
Intervention: Drug: Ranibizumab (Lucentis)
2 Completed Intravitreal Injections of Ziv-aflibercept for Macular Diseases
Conditions: Diabetic Macular Edema;   Age Related Macular Degeneration;   Branch Retinal Vein Occlusion With Macular Edema;   Central Retinal Vein Occlusion With Macular Edema
Intervention: Drug: Intravitreal injections of ziv-aflibercept

Study has passed its completion date and status has not been verified in more than two years.